OpenEvidence, an ad-driven AI healthcare startup valued at $15 billion, is reportedly used by nearly two-thirds of physicians across the United States.
Miami-based AI-powered medical search platform OpenEvidence, founded in 2022, claims that nearly two-thirds of U.S. physicians use its ad-supported AI chat tool to retrieve medical literature and clinical guidelines, processing over 42 million medical queries per month. The company is currently valued at $15 billion, though its accuracy and advertising model have sparked controversy regarding the safety of clinical decision-making.